In-licensed product Natulan® (Procarbazine Hydrochloride Capsules) was successfully launched in China

In-licensed product Natulan® (Procarbazine Hydrochloride Capsules) was successfully launched in China

April 24, 2023, Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950) announced that its in-licensed product Natulan® (Procarbazine Hydrochloride Capsules, formerly known as Procarbazine), was successfully launched in China and was distributed from its Guangzhou Nansha manufacturing site across the country.

ดาวน์โหลดข่าวฉบับเต็ม (PDF)

ที่มา: Lee’s Pharmaceutical Holdings – News & Media

ข่าวสารอื่นๆ

thThai